J Am Pharm Assoc (2003). 2019 Mar-Apr;59(2S):S13-S17. doi: 10.1016/j.japh.2018.10.002. Epub 2018 Nov 15.
Nonprescription or over-the-counter (OTC) medications play a crucial role in a patient's ability to make choices to manage his or her own health care. Often these nonprescription choices are unknown to health care practitioners and thus are often not included as part of patients' health records. The exclusion of these therapies can pose risks to patient safety. There is a significant need to address the capture of OTC medication use in both the physician and pharmacy electronic health records (EHRs) and during the practitioner-patient medication history and reconciliation process.
On October 26, 2016, the National Association of Chain Drug Stores Foundation hosted a forum for a select group of health care industry professionals to work on a series of recommendations to improve the documentation of OTC medication use by patients. This diverse group of more than a dozen stakeholders included community pharmacy leaders from multiple chain pharmacies, pharmacy system vendors, e-prescribing vendors, health information technology experts, and multiple industry representatives, including individuals from the public sector. This commentary is a summary of the insights and suggestions where the group was in general agreement.
Successful OTC medication EHR integration will require system-level buy-in across multiple layers of the health care industry to improve patient safety. Forum participants suggested incremental steps that could be taken by multiple stakeholders to lay the foundation for integration within an appropriate regulatory structure.
Based on the results of the stakeholder forum, an agreement formed around one approach that the group supported as feasible: the creation of a consistent and uniform identification method for OTC medications in cooperation with government regulatory authorities.
非处方或柜台(OTC)药物在患者管理自身医疗保健方面发挥着至关重要的作用。这些非处方选择通常不为医疗保健从业者所知,因此通常不包括在患者的健康记录中。这些疗法的排除可能会对患者的安全构成风险。因此,非常有必要解决在医生和药房电子健康记录(EHR)中以及在医生-患者用药史和药物重整过程中记录 OTC 药物使用情况的问题。
2016 年 10 月 26 日,全国连锁药店基金会举办了一个论坛,邀请了一组精选的医疗保健行业专业人士,共同制定了一系列建议,以改进患者对 OTC 药物使用情况的记录。这个由十多名利益相关者组成的多元化团体包括来自多家连锁药店的社区药店领导、药店系统供应商、电子处方供应商、健康信息技术专家以及多个行业代表,其中包括来自公共部门的个人。本评论是对该团体普遍达成一致意见的见解和建议的总结。
成功实现 OTC 药物 EHR 集成需要医疗保健行业多个层面的系统级认可,以提高患者的安全性。论坛参与者建议多个利益相关者可以采取逐步措施,为在适当的监管结构内进行整合奠定基础。
基于利益相关者论坛的结果,该团体形成了一个共识,支持一种可行的方法:与政府监管机构合作,为 OTC 药物创建一种一致和统一的识别方法。